Tag: Disease-modifying antirheumatic drugs

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Disease-modifying antirheumatic drugs

Lilly touts Omvoh's superiority over J&J's Stelara in Crohn's - Clinical Trials Arena

Added to Collection on: 2024-10-15 14:33:59

Tags for this article:

Autoimmune diseases
Immunosuppressants
Monoclonal antibodies
Disease-modifying antirheumatic drugs
Abdominal pain
Biosimilar
Adalimumab
Crohn's disease
Inflammatory bowel disease
Eli Lilly and Company
Ulcerative colitis
Clinical trial

Click the tags to see associated articles and topics

View Article Details
Axial Spondyloarthritis Market on Track for Major Expansion by 2034, According to DelveInsight

Added to Collection on: 2024-10-23 15:17:12

Tags for this article:

Monoclonal antibodies
Arthritis
Disease-modifying antirheumatic drugs
Biotechnology
Immunosuppressants
Spondyloarthritis
Certolizumab pegol
Axial spondyloarthritis
Bimekizumab
Ankylosing spondylitis
Biopharmaceutical
Ixekizumab
Eli Lilly and Company
Janssen Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Psoriasis biosimilars and pricing changes herald treatment paradigm disruptions

Added to Collection on: 2024-10-31 13:05:31

Tags for this article:

Immunosuppressants
Monoclonal antibodies
Disease-modifying antirheumatic drugs
TNF inhibitors
Pharmacy
Biosimilar
Biopharmaceutical
Psoriasis
Adalimumab
Ustekinumab
Etanercept
Amgen
Robert Popovian
United States
Stelara

Click the tags to see associated articles and topics

View Article Details
Biosimilars Month in Review: October 2024 - HCPLive

Added to Collection on: 2024-11-02 18:03:59

Tags for this article:

Immunosuppressants
Monoclonal antibodies
Disease-modifying antirheumatic drugs
TNF inhibitors
Janssen Biotech
Biosimilar
Adalimumab
Infliximab
Ustekinumab
Etanercept
Ulcerative colitis
Crohn's disease

Click the tags to see associated articles and topics

View Article Details
Alopecia - Current Treatment - Treatment Algorithms: Claims Data Analysis - Alopecia Areata (US)

Added to Collection on: 2024-11-01 21:05:33

Tags for this article:

Hair diseases
Human hair
Disease-modifying antirheumatic drugs
Autoimmune diseases
Alopecia areata
Janus kinase inhibitor
Hair loss
Baricitinib
Tofacitinib

Click the tags to see associated articles and topics

View Article Details
Alpha-Gal May Drive Sensitivity to IV Stelara in People With Red-Meat Allergies

Added to Collection on: 2024-12-14 22:31:52

Tags for this article:

Monoclonal antibodies
Immunosuppressants
Disease-modifying antirheumatic drugs
Janssen Biotech
Orphan drugs
Ustekinumab
Vedolizumab
Infliximab
Adalimumab
Immunoglobulin E
Hypersensitivity
Alpha-gal syndrome

Click the tags to see associated articles and topics

View Article Details
Biologics Market Size to Worth USD 1,044.2 Million By 2031 - BioSpace

Added to Collection on: 2025-01-02 23:09:02

Tags for this article:

Biotechnology
Biotechnology products
Disease-modifying antirheumatic drugs
Immunosuppressants
Biopharmaceuticals
Biosimilar
AstraZeneca
Vaccine
Novartis
Eli Lilly and Company
Food and Drug Administration
Merck & Co.

Click the tags to see associated articles and topics

View Article Details
EC Grants Marketing Authorization to Celltrion Biosimilar for Arthritis Treatment

Added to Collection on: 2025-02-26 16:30:54

Tags for this article:

Monoclonal antibodies
Orphan drugs
Specialty drugs
Immunosuppressants
Disease-modifying antirheumatic drugs
Celltrion
Tocilizumab
Regdanvimab
Bevacizumab
Biosimilar
Genentech
Biopharmaceutical

Click the tags to see associated articles and topics

View Article Details
Bioengineered Protein Drugs Market: Surging from US$347.1 Bn in 2023 to US$672.7 Bn by 2034

Added to Collection on: 2025-03-03 15:29:53

Tags for this article:

Pharmacy
Biotechnology
Biotechnology products
Biopharmaceuticals
Disease-modifying antirheumatic drugs
Biosimilar
BioMarin Pharmaceutical
Adalimumab
Amgen
Pharmaceutical industry
Autoimmune disease
Chronic condition

Click the tags to see associated articles and topics

View Article Details
Bioengineered Protein Drugs Market Size to Cross USD 672.7 - GlobeNewswire

Added to Collection on: 2025-03-13 22:07:55

Tags for this article:

Pharmacy
Disease-modifying antirheumatic drugs
Immunosuppressants
TNF inhibitors
Biotechnology
Biopharmaceutical
Biosimilar
Biocon
Pharmaceutical industry
Etanercept
Adalimumab
Amgen
United States
Wilmington

Click the tags to see associated articles and topics

View Article Details